1

2

3

4

5

is No.2 in the Japanese market

and it has a solid reputation as a leader

in research based medicine; has invested

around 1.345 (bn$) in research &

development in 2008 with a total

commitment to further investment,

& has research & development units at

over 15 locations all around the world

including North America, Europe & Asia.

is the No. 3 in the Japanese market

& has invested 1.64 (bn$) in research &

development in 2008 and will continue

to invest with a number of major

products in the research & development

pipeline, which is well positioned to

meet the healthcare needs of the future.

6

7

8

Japanese PharmaceuticalTechnology

Unique Standards & Specifications

9

10

Green Area

11

Lent free special coat

Double door air shower

12

Digital Reading facility

for each room

13

Unique Visual inspection

14

15